The-124C>T Mutation of TERT Promoter Indicates a Favorable Prognosis in OCCC: A Monoinstitutional Study in China

被引：0
|
作者：
Zhou, Xiaonan [1 ]
Liu, Yifei [2 ]
Hu, Jue [1 ]
Zhang, Jing [1 ]
Ren, Min [2 ]
Ji, Gang [1 ]
Cai, Xu [2 ]
Bi, Rui [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1025
引用
收藏
页码：S1276 / S1277
页数：2
相关论文
共 16 条
  • [1] TERT Promoter Mutation c.-124C>T Commonly Occurs in Low-Grade Fibromatosis-like Metaplastic Breast Carcinoma
    Webersinke, Gerald
    Burghofer, Jonathan
    Malli, Theodora
    Rammer, Melanie
    Jahn, Stephan Wenzel
    Niendorf, Axel
    Tavassoli, Fattaneh A.
    Moinfar, Farid
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2023, 147 (12) : 1451 - 1457
  • [2] The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors
    Liu, Tiantian
    Brown, Taylor C.
    Juhlin, C. Christofer
    Andreasson, Adam
    Wang, Na
    Backdahl, Martin
    Healy, James M.
    Prasad, Manju L.
    Korah, Reju
    Carling, Tobias
    Xu, Dawei
    Larsson, Catharina
    ENDOCRINE-RELATED CANCER, 2014, 21 (03) : 427 - 434
  • [3] Favorable Impact of Serum TERT C228T for Prognosis after Surgical Resection for Liver Cancer
    Akuta, Norio
    Kawamura, Yusuke
    Fujiyama, Shunichiro
    Sezaki, Hitomi
    Hosaka, Tetsuya
    Saitoh, Satoshi
    Kobayashi, Mariko
    Arase, Yasuji
    Ikeda, Kenji
    Suzuki, Yoshiyuki
    Kumada, Hiromitsu
    Suzuki, Fumitaka
    ONCOLOGY, 2023, 101 (11) : 738 - 752
  • [4] Detection of TERT Promoter Mutation C228T in Solitary Fibrous Tumours: A Pathology Summer Studentship Experience
    Connolly, C.
    Butters, T.
    Flanagan, A. M.
    Cottone, L.
    JOURNAL OF PATHOLOGY, 2022, 256 : S16 - S16
  • [5] TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations
    Arita, Hideyuki
    Matsushita, Yuko
    Machida, Ryunosuke
    Yamasaki, Kai
    Hata, Nobuhiro
    Ohno, Makoto
    Yamaguchi, Shigeru
    Sasayama, Takashi
    Tanaka, Shota
    Higuchi, Fumi
    Iuchi, Toshihiko
    Saito, Kuniaki
    Kanamori, Masayuki
    Matsuda, Ken-ichiro
    Miyake, Yohei
    Tamura, Kaoru
    Tamai, Sho
    Nakamura, Taishi
    Uda, Takehiro
    Okita, Yoshiko
    Fukai, Junya
    Sakamoto, Daisuke
    Hattori, Yasuhiko
    Pareira, Eriel Sandika
    Hatae, Ryusuke
    Ishi, Yukitomo
    Miyakita, Yasuji
    Tanaka, Kazuhiro
    Takayanagi, Shunsaku
    Otani, Ryohei
    Sakaida, Tsukasa
    Kobayashi, Keiichi
    Saito, Ryuta
    Kurozumi, Kazuhiko
    Shofuda, Tomoko
    Nonaka, Masahiro
    Suzuki, Hiroyoshi
    Shibuya, Makoto
    Komori, Takashi
    Sasaki, Hikaru
    Mizoguchi, Masahiro
    Kishima, Haruhiko
    Nakada, Mitsutoshi
    Sonoda, Yukihiko
    Tominaga, Teiji
    Nagane, Motoo
    Nishikawa, Ryo
    Kanemura, Yonehiro
    Kuchiba, Aya
    Narita, Yoshitaka
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2020, 8 (01)
  • [6] TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations
    Hideyuki Arita
    Yuko Matsushita
    Ryunosuke Machida
    Kai Yamasaki
    Nobuhiro Hata
    Makoto Ohno
    Shigeru Yamaguchi
    Takashi Sasayama
    Shota Tanaka
    Fumi Higuchi
    Toshihiko Iuchi
    Kuniaki Saito
    Masayuki Kanamori
    Ken-ichiro Matsuda
    Yohei Miyake
    Kaoru Tamura
    Sho Tamai
    Taishi Nakamura
    Takehiro Uda
    Yoshiko Okita
    Junya Fukai
    Daisuke Sakamoto
    Yasuhiko Hattori
    Eriel Sandika Pareira
    Ryusuke Hatae
    Yukitomo Ishi
    Yasuji Miyakita
    Kazuhiro Tanaka
    Shunsaku Takayanagi
    Ryohei Otani
    Tsukasa Sakaida
    Keiichi Kobayashi
    Ryuta Saito
    Kazuhiko Kurozumi
    Tomoko Shofuda
    Masahiro Nonaka
    Hiroyoshi Suzuki
    Makoto Shibuya
    Takashi Komori
    Hikaru Sasaki
    Masahiro Mizoguchi
    Haruhiko Kishima
    Mitsutoshi Nakada
    Yukihiko Sonoda
    Teiji Tominaga
    Motoo Nagane
    Ryo Nishikawa
    Yonehiro Kanemura
    Aya Kuchiba
    Yoshitaka Narita
    Acta Neuropathologica Communications, 8
  • [7] TERT promoter C228T mutation in neural progenitors confers growth advantage following telomere shortening in vivo
    Miki, Shunichiro
    Koga, Tomoyuki
    Mckinney, Andrew M.
    Parisian, Alison D.
    Tadokoro, Takahiro
    Vadla, Raghavendra
    Masala, Martin
    Hevner, Robert F.
    Costello, Joseph F.
    Furnari, Frank
    NEURO-ONCOLOGY, 2022, 24 (12) : 2063 - 2075
  • [8] The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer
    Li, Chong
    Wu, Song
    Wang, Haifeng
    Bi, Xingang
    Yang, Zhao
    Du, Ying
    He, Luyun
    Cai, Zhiming
    Wang, Jiansong
    Fan, Zusen
    ONCOTARGET, 2015, 6 (23) : 19542 - 19551
  • [9] HAMP promoter mutation nc.-153C>T in 785 HEIRS Study participants
    Barton, James C.
    Letendecker-Foster, Catherine
    Li, Honggui
    DelRio-LaFrentere, Susie
    Acton, Ronald T.
    Eckfeldt, John H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (10): : 1465 - 1465
  • [10] Detection of TERT C228T and C250T promoter mutations in melanoma tumor and plasma samples using novel mutation-specific droplet digital PCR assays
    Corless, Broderick
    Chang, Gregory
    Cooper, Samantha
    Syeda, Mahrukh
    Osman, Iman
    Karlin-Neumann, George
    Polsky, David
    CANCER RESEARCH, 2017, 77
12